Anthony Restaino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anthony Restaino has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
- Hannah Wollenzien
Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota
115 shared publications - Michael S. Kareta
Cancer Biology and Immunotherapies Group, Sanford Research, Sioux Falls, South Dakota
115 shared publications - Robert Szczepaniak-Sloane
Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
115 shared publications - Yohannes Afeworki Tecleab
Functional Genomics and Bioinformatics Core, Sanford Research, Sioux Falls, South Dakota
115 shared publications - Paola Drapkin Vermeer
Sanford Research
9 shared publications - Sebastien Talbot
Karolinska Institute
6 shared publications
Latest Publications
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S6 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Expression and validation of AP-1 family genes in late tumor development.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S6 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Expression and validation of AP-1 family genes in late tumor development.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
SCLC Subtype-specific marker expression from the RPR2-Cas9 mouse model.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
SCLC Subtype-specific marker expression from the RPR2-Cas9 mouse model.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Characterization of cell types isolated from the autochthonous scRNA-seq data.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Characterization of cell types isolated from the autochthonous scRNA-seq data.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Description of samples in the xenograft study
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Description of samples in the xenograft study
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Validation of the autochthonous barcoding model.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Validation of the autochthonous barcoding model.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S5 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Cell cycle stage assignment of the SCLC cells from the autochthonous model.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S5 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Cell cycle stage assignment of the SCLC cells from the autochthonous model.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S8 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Validation of the LBC labeling and xenograft growth.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S8 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Validation of the LBC labeling and xenograft growth.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S12 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
GAGE2A and PAGE5 upregulation upon treatment of cisplatin and etoposide.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S12 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
GAGE2A and PAGE5 upregulation upon treatment of cisplatin and etoposide.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Graphic displaying the sample makeup of the three NCI-H209 sample arms.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Graphic displaying the sample makeup of the three NCI-H209 sample arms.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S14 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Validation of GAGE2A and PAGE5 shRNAs and overexpression vectors.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S14 from Single-Cell Evolutionary Analysis Reveals Drivers of Plasticity and Mediators of Chemoresistance in Small Cell Lung Cancer
Validation of GAGE2A and PAGE5 shRNAs and overexpression vectors.